7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
Chemotherapy and Myeloma Myeloma Infoguide Series
March 08
12:54
Page 1
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 2
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 1
Contents 2
Introduction
3
What is myeloma?
4
What is chemotherapy?
5
Decisions about chemotherapy treatment
8
How is chemotherapy used to treat myeloma?
16
Chemotherapy for myeloma patients with kidney problems
17
Before you start chemotherapy treatment
21
Side-effects of chemotherapy treatment
26
How do I know if my chemotherapy treatment is working?
27
The emotional impact of chemotherapy treatment
30
The future
31
Questions for your doctor / medical team
33
Medical terms explained
37
Further information and useful organisations
40
With Myeloma UK you can ...
41
Other information available from Myeloma UK
42
We need your help
Disclaimer The information in this Infoguide is not meant to replace the advice of your medical team. They are the best people to ask if you have questions about your individual situation.
Myeloma Infoline 0800 980 3332
1
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 2
Introduction This Infoguide is written for patients with myeloma, their families and friends It provides information about chemotherapy when used as a treatment for myeloma. This Infoguide reviews what chemotherapy is, how it works, when it is used in myeloma, what to expect from chemotherapy treatment and which potential sideeffects may occur. Some of the more technical or unusual words appear in bold the first time they are used and are explained in the medical terms explained section at the back of the Infoguide Aims of this Infoguide • To provide you with more information about chemotherapy as a treatment for myeloma • To answer some of the more common questions about chemotherapy • To help you make informed decisions about the treatment options available Myeloma UK provides a range of specific Infoguides and Infosheets which cover all aspects of the treatment and management of myeloma. You will find a list of them at the back of this Infoguide. If you would like a more general overview of what myeloma is, how it is diagnosed, the most commonly used treatments and many of the things you may have to cope with in living with myeloma, please see ‘Myeloma - Your Essential Guide’ and ‘Living with Myeloma - Your Essential Guide’. To order your free copies contact the Myeloma Infoline on 0800 980 3332. This information is also available to download at www.myeloma.org.uk If you would like to talk to someone about any aspect of myeloma, its treatment and management, call the Myeloma Infoline on 0800 980 3332. Your call will be answered by Myeloma Information Nurse Specialists who are supported by medical advisors. The Myeloma Infoline is open Monday to Friday, 9am to 5pm, and is free to phone from anywhere in the UK. From outside the UK, call +44 131 557 3332 (charged at normal rate).
2
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 3
What is myeloma? Myeloma, also known as multiple myeloma, is a type of bone marrow cancer arising from plasma cells, which are normally found in the bone marrow. Plasma cells form part of your immune system. Normal plasma cells produce antibodies (also called immunoglobulins) to help fight infection. In myeloma, the abnormal plasma cells release only one type of antibody known as paraprotein, which has no useful function. It is often through the identification and measurement of this paraprotein that myeloma is diagnosed and monitored. Bone marrow is the 'spongy' material found in the centre of larger bones in the body. As well as being home to plasma cells, the bone marrow is the centre of blood cell production (i.e red blood cells, white blood cells and platelets). Our bodies are made up of a range of organs, tissues and fluid - all of which consist of thousands of cells. A cell is the smallest living unit in your body and contains genetic material (DNA) that is unique to you. Normally, cells throughout your body divide and multiply in an orderly and controlled manner. This process ensures that cells are continuously replaced by new ones when needed. A cancer develops when there is a disruption in the normal process of cell division, where one or more cells start to grow in an uncontrolled or abnormal way. In myeloma, the DNA of a plasma cell is damaged causing it to become cancerous (malignant). These abnormal plasma cells are known as myeloma cells and continue to grow uncontrollably unless the process is actively halted. Unlike many cancers, myeloma does not exist as a lump or tumour. Instead, the myeloma cells usually divide and expand within the bone marrow. Myeloma typically affects a number of places in the body where bone marrow is normally active in an adult, i.e. within the bones of the spine, skull, pelvis and the rib cage, as well as the areas around the shoulders and hips (hence the term multiple myeloma).
Myeloma Infoline 0800 980 3332
3
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 4
What is chemotherapy? The term chemotherapy is derived from the words 'chemical' and 'therapy' and is the name used to describe a range of treatments aimed at destroying cancer cells. Chemotherapy is also referred to as being cytotoxic, which means that it is toxic or poisonous to cells. The first use of chemotherapy was in the 1940s. Since then, great advances have been made in the field of chemotherapy and other types of cancer treatment.
How does chemotherapy work in myeloma? Chemotherapy treatments interfere with the way that myeloma cells multiply and divide, and, in doing so, aim to stop or slow down their growth. One of the ways that chemotherapy works is by destroying cells in the body that are in the process of rapid cell division. As myeloma cells divide more rapidly than normal cells, they are particularly sensitive to the effects of chemotherapy. There are different groups of chemotherapy treatments, grouped according to how they work. These groups include: • Alkylating agents: these directly damage the DNA within the cell, preventing cells from reproducing, e.g. melphalan, cyclophosphamide • Plant alkaloids: these stop the process of cell division and primarily work during the phase of the cell cycle where the cell is duplicating DNA before cell division, e.g vincristine • Cytotoxic antibiotics: these interfere with specific enzymes involved in the duplication of DNA in the cell, e.g. doxorubicin Doctors often use other anti-myeloma treatments alongside chemotherapy, such as: • Steroids, e.g. dexamethasone, prednisolone • Immunomodulatory treatments, e.g. thalidomide, REVLIMID® (lenalidomide) • Proteasome inhibitor, e.g. VELCADE® (bortezomib)
4
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 5
Decisions about chemotherapy treatment Not everyone diagnosed with myeloma will need treatment immediately. If your myeloma is not causing symptoms (asymptomatic or smouldering myeloma), the risks of having chemotherapy treatment will often outweigh the potential benefits. On the other hand, if your myeloma is causing symptoms at diagnosis, or has come back after previous treatment, then your doctor will talk to you about possible treatment options. There is an increasing range of effective treatments for myeloma. Some people prefer to take an active role in the treatment decision-making process and it is important to have the opportunity to discuss all treatment options with your doctor. In making a decision about any myeloma treatment, including chemotherapy, you and your doctor will take into account: • • • • •
Your overall general health and any existing medical problems Your age Any myeloma-related complications, e.g. kidney problems Your personal circumstances, lifestyle and preferences The response you have had to any previous treatment
Try to gain as much information as you need to help you understand and make decisions about your treatment. Information is available from many sources, including your doctors and nurses, Myeloma UK and reputable internet sites. Talking things over with your family, friends or another myeloma patient can also help to clarify your thoughts and work out your personal priorities. The important thing is that you and your doctor decide and agree together on the treatment you will receive.
Myeloma Infoline 0800 980 3332
5
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 6
Getting more than one opinion The way myeloma services are currently organised in the UK means that the hospital where you are treated should involve a range of healthcare professionals working together as a team, known as a multidisciplinary team (MDT). The MDT is likely to discuss management of your myeloma, although often only one doctor (usually the consultant haematologist) will have overall responsibility for your treatment and care. Choosing the right treatment is not always straightforward and some people may feel that they want another opinion, to be sure that the treatment plan is appropriate for them. Doctors are normally happy to arrange a consultation with another doctor, and can usually arrange this on the NHS, although some people may choose to go privately. The second doctor should ideally have your notes or case history before the consultation, so they are familiar with your situation. If you would prefer to seek a consultation with a doctor in a different part of the country you will need to check the local procedure for this. There may be other reasons for wanting to see another doctor, such as a difficulty in communicating with your doctor. In this circumstance, you might ask to see a different doctor, either in the same hospital or at a nearby hospital.
What if I don’t want any chemotherapy treatment at all? If you choose not to have active treatment for your myeloma, e.g. with chemotherapy, there are many supportive treatments to help alleviate some of the symptoms of your disease and thus improve your quality of life. There may also be some complementary treatments available to help control symptoms. However, it is important that you speak to your doctor about any complementary treatment you would like to take and consult a qualified complementary therapist who has experience of treating patients with myeloma. Some people may wish to delay starting their chemotherapy treatment, perhaps because of personal or family commitments. Whether this is possible or not will depend on a number of individual and myeloma-related factors, and will require an in-depth discussion with your doctor.
6
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 7
Very occasionally, some people choose to try alternative approaches to treat their myeloma, instead of conventional treatments. Alternative treatments are not tested with the same rigour as conventional treatments, which means there is often no, or at best very little, evidence to support their use. If you decide that an alternative approach is something you would like to try as a way of treating your myeloma, it is important to discuss this fully with your doctor as there are potential risks involved.
Advantages and disadvantages of chemotherapy treatment As with any anti-cancer treatment, any benefits of chemotherapy have to be weighed up against the potential risks and side-effects. The main advantages of chemotherapy treatment include: • It is a well-proven treatment approach for myeloma and is effective in killing myeloma cells. In addition, it can reduce symptoms and improve quality of life • You can have most chemotherapy treatments at home or as an outpatient The main disadvantages include: • Chemotherapy can cause some unpleasant and occasionally harmful side-effects, although these are almost always temporary • Over time, myeloma cells can sometimes become resistant to chemotherapy. If this happens, your doctor may suggest you try a different type of chemotherapy or a different treatment altogether (e.g. thalidomide or Velcade)
Myeloma Infoline 0800 980 3332
7
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 8
How is chemotherapy used to treat myeloma? Broadly speaking, chemotherapy is used to reduce or eliminate the number of detectable myeloma cells in your bone marrow, control any symptoms such as pain, and improve your quality of life. You can have chemotherapy at various stages in myeloma as outlined below: • Younger and / or fitter patients will usually be considered for high-dose chemotherapy and stem cell transplant, and will therefore follow an 'intensive treatment pathway' • Older and / or less fit patients will usually follow a less intensive treatment pathway, without high-dose chemotherapy and stem cell transplant
Intensive treatment pathway There are many effective chemotherapy combinations available for younger and / or fitter patients as part of their initial treatment for myeloma. When a patient is going on to have high-dose chemotherapy and stem cell transplantation, the initial chemotherapy is often called induction treatment. The aim of induction chemotherapy, before high-dose chemotherapy and stem cell transplant, is to achieve a rapid reduction of your myeloma cells without damaging stem cells and the ability to later collect them. If you respond to induction chemotherapy you will go on to have your stem cells collected, followed by treatment with high-dose chemotherapy (known as conditioning). This can potentially kill more myeloma cells than is possible with standard chemotherapy doses. High-dose chemotherapy damages normal cells in the bone marrow as well as myeloma cells, and therefore a stem cell transplant is necessary so that the transplanted stem cells can begin making new blood cells. In myeloma, most stem cell transplants use the patient’s own cells. This is known as an 'autologous' stem cell transplant. Occasionally, stem cells from a donor (usually a sibling) are used; this is known as an 'allogeneic' stem cell transplant. The conditioning chemotherapy used in transplantation is usually high-dose melphalan, although you might have other types of chemotherapy for an allogeneic stem cell transplant. 8
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 9
For more information please see the ‘High-Dose Therapy and Stem Cell Transplantation’ Infoguide from Myeloma UK. To order your free copy, contact the Myeloma Infoline on 0800 980 3332.
Non-intensive treatment pathway As with the intensive pathway, there are many effective chemotherapy combinations available for older and / or less fit patients. Current research indicates that some of these chemotherapy combinations offer just as good a response as that seen with more intensive chemotherapy combinations for younger and / or fitter patients. When high-dose chemotherapy and stem cell transplant is not an option, the aim of chemotherapy is still to achieve a maximum reduction in the number of myeloma cells with the smaller degree of side-effects. In this setting, oral chemotherapy combinations are most commonly used. Whether you have intensive or non-intensive treatment, both individual and myelomarelated factors will determine the exact course and type of chemotherapy you receive. Quite often you will have your chemotherapy in combination with other nonchemotherapy treatments, such as thalidomide and steroids.
Chemotherapy treatment for refractory myeloma If your myeloma does not respond (is refractory) to initial or induction chemotherapy, there will still be, for most patients, a number of effective treatment options available, using different types of chemotherapy in a variety of combinations.
Chemotherapy treatment for relapsed myeloma Unfortunately, at some point myeloma usually returns (relapses). Though this is always disappointing, there may still be many treatment options available to you. Again, the aim of chemotherapy in this setting is to gain control of the myeloma, relieve any symptoms and to improve your quality of life. If your response to initial chemotherapy treatment was good, then repeating this may be a good option. If, however, your myeloma did not respond well your doctor may suggest using a different type, or combination, of chemotherapy. Myeloma Infoline 0800 980 3332
9
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 10
Chemotherapy treatment for symptom control In more advanced stages of myeloma doctors might prescribe chemotherapy with the main aim being to promote relief from pain or other symptoms, rather than the direct control of the myeloma itself. In this setting, the dose and intensity of the chemotherapy will be much lower, so as to minimise potential side-effects.
Chemotherapy treatment as part of clinical studies You may sometimes have chemotherapy as part of a clinical study. The purpose of clinical studies is to try and find the most effective treatments for patients. In myeloma, clinical studies are particularly useful in comparing newer treatments with current standard treatments. For more information please see the ‘Clinical Studies’ Infoguide from Myeloma UK. To order your free copy, contact the Myeloma Infoline on 0800 980 3332.
Common chemotherapy combinations used in myeloma The following tables outline some of the common and newer chemotherapy combinations used at different stages of myeloma • Table1 • Table 2 • Table 3 • Table 4 -
10
Induction chemotherapy combinations prior to high-dose chemotherapy and stem cell transplant Non-intensive initial chemotherapy Chemotherapy for refractory myeloma Chemotherapy for relapsed myeloma
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
Table 1 -
17/3/08
12:54
Page 11
Induction chemotherapy combinations prior to high-dose chemotherapy and stem cell transplant
Treatment combination
Advantages
Disadvantages
CTD Cyclophosphamide Thalidomide Dexamethasone
Taken orally No stem cell damage Responses in 70% of patients
Potential side-effects with thalidomide: thrombosis / neurological complications
Responses in 70% of patients Does not damage stem cells Forms basis for stem cell transplant Symptoms of active disease may be controlled rapidly and quality of first remission may be good
Intravenous (IV) administration requiring a semi-permanent line Vincristine can cause nerve damage
As above
As above
As above
As above
As above
As above
Taken orally No stem cell damage
Potential side-effects with Idarubicin: lowered blood counts
VAD Vincristine Doxorubicin* Dexamethasone *Doxorubicin was previously known as Adriamycin Note: This combination used to be the standard treatment but it is used less commonly now C-VAD Cyclophosphamide Vincristine Doxorubicin Dexamethasone C-VAMP Cyclophosphamide Vincristine Doxorubicin Methlyprednisolone VAMP Vincristine Doxorubicin Methlyprednisolone Z-DEX Idarubicin* Dexamethasone (* Also called Zavedos速)
Myeloma Infoline 0800 980 3332
11
7936 Chemo infoguide.qxp:6732 infoguide
Table 1 -
17/3/08
12:54
Page 12
Induction chemotherapy combinations prior to high-dose chemotherapy and stem cell transplant
Treatment combination
Advantages
Disadvantages
No stem cell damage
Potential side-effects with thalidomide: thrombosis / neurological complications IV administration requiring a semipermanent line Vincristine can cause nerve damage
No stem cell damage
IV administration Frequent hospital visits required Potential side-effects with Velcade: neurological complications
As above
As above
Newer / In clinical study T-VAD Thalidomide Vincristine Doxorubicin Dexamethasone
PAD Velcade* Doxorubicin Dexamethasone (* Velcade was originally known as PS341) VD Velcade Doxorubicin
For more information, please see the ‘High-Dose Therapy and Stem Cell Transplantation’ Infoguide from Myeloma UK. To order your free copy, contact the Myeloma Infoline on 0800 980 3332.
12
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 13
Table 2 - Initial non-intensive chemotherapy approaches (when high-dose therapy and stem cell transplant is not planned) Treatment approach
Advantages
Disadvantages
Taken orally Well tolerated Responses in 50% of patients Well established combination
Potential side-effects: stomach upsets and reduced blood counts
Oral administration
Potential side-effects with thalidomide: thrombosis / neurological complications
Melphalan
Oral administration
Potentially less effective than combination chemotherapy
CP Cyclophosphamide Prednisolone
Oral administration
Potential side-effects: stomach upsets and bladder irritation
Cyclophosphamide
Oral administration
Potentially less effective than combination chemotherapy
MP Melphalan Prednisolone
MPT Melphalan Prednisolone Thalidomide
Newer / In clinical study VMP Velcade Melphalan Prednisolone
Potentially effective combination
Myeloma Infoline 0800 980 3332
IV administration Frequent hospital visits Potential side-effects with Velcade; neurological complications
13
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 14
Table 3 - Chemotherapy combinations for refractory myeloma Treatment combination ESHAP Etoposide Methylprednisolone Cytarabine Cisplatinum DCEP Dexamethasone Cyclophosphamide Etoposide Cisplatinum
Advantages
Disadvantages
Can be used to mobilise stem IV administration usually involves cells a stay in hospital
Potentially effective combination
IV administration usually involves a stay in hospital
Taken orally
Potential side-effects with thalidomide: thrombosis / neurological complications
Taken orally No stem cell damage Response in 70% of patients
Potential side-effects with thalidomide: thrombosis / neurological complications
VTD Velcade Thalidomide Dexamethasone
No stem cell damage (significant if stem cell transplant is still an option)
IV administration Frequent hospital visits required Potential side-effects with thalidomide: thrombosis / neurological complications Potential side-effects with Velcade: neurological complications
PAD Velcade Doxorubicin Dexamethasone
No stem cell damage (significant if stem cell transplant is still an option)
IV administration Frequent hospital visits required Potential side-effects with Velcade: neurological complications
Potentially effective combination
IV administration usually involves a stay in hospital Potential side-effects with thalidomide: thrombosis / neurological complications
MPT Melphalan Prednisolone Thalidomide CTD Cyclophosphamide Thalidomide Dexamethasone Newer / In clinical study
DT PACE Dexamethasone Thalidomide Cisplatin Doxorubicin Cyclophosphamide Etoposide 14
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 15
Table 4 - Chemotherapy approaches for relapsed myeloma Treatment combination
Advantages
Disadvantages
T Thalidomide
Taken orally
Potential side-effects with thalidomide: thrombosis / neurological complications
Taken orally
Potential side-effects with thalidomide: thrombosis / neurological complications
Taken orally
No stem cell damage Potential side-effects with thalidomide: thrombosis / neurological complications
Potentially effective combination
IV administration requiring a semi-permanent line Vincristine can cause nerve damage
As above
As above
Taken orally Well tolerated Response in 50% of patients Well established combination
Potential side-effects: stomach upsets and reduced blood counts
M Melphalan
Taken orally
Potentially less effective than combination chemotherapy
C Cyclophosphamide
Taken orally
Potentially less effective than combination chemotherapy
MPT Melphalan Prednisolone Thalidomide CTD Cyclophosphamide Thalidomide Dexamethasone C-VAD Cyclophosphamide Vincristine Doxorubicin Dexamethasone
C-VAMP Cyclophosphamide Vincristine Doxorubicin Methlyprednisolone MP Melphalan Prednisolone
Myeloma Infoline 0800 980 3332
15
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 16
Chemotherapy for myeloma patients with kidney problems The abnormal 'paraprotein' produced by myeloma cells can sometimes cause kidney problems. If your kidney function is poor (due to either myeloma or any pre-existing condition), it is normally still possible to have chemotherapy. Younger and / or fitter patients with myeloma and kidney problems can also be considered candidates for high-dose chemotherapy and stem cell transplant.
Table 5 - Chemotherapy approaches used with kidney problems Treatment
Comments
VAD
Treatment of choice in patients with kidney problems
Dexamethasone
As above
Melphalan
Dose reduction is often needed
Cyclophosphamide
Dose reduction is often needed
16
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 17
Before you start chemotherapy treatment Before you start chemotherapy, you will need to have some tests and investigations. These provide a set of results to compare with future tests, allowing your doctor to check your response to chemotherapy. Tests include: • Blood tests (you will normally have a blood sample taken before the start of each treatment cycle) • Urine tests (to measure any paraprotein as well as to detect infection) • X-rays (to monitor any bone damage) • Height and weight measurement (used to calculate the dose of chemotherapy and to check for possible weight changes) Depending on the type of chemotherapy planned, you may also need your heart function checked. If this is the case, you might have an: • Electrocardiogram (ECG) - an electrical tracing of your heart beat • Echo cardiogram - an ultrasound of the heart After these tests are complete, your doctor, and / or nurse, will talk you through the treatment plan, detailing when, where and how you will have your chemotherapy, as well as explaining the potential side-effects. Remember that this is your chance to gain as much information as you feel you need, so make sure you ask your doctor, and / or nurse, any questions you may have. You should make sure that you have the details of whom to contact if you have questions, an unexpected side-effect or an emergency during your treatment. It may also be worth spending a bit of time, before your chemotherapy begins, to think about any practical plans you need to make. For example: • How you will get to the hospital? • Who, if anyone, might come to hospital with you? • Are there any family or work arrangements you need to make?
Myeloma Infoline 0800 980 3332
17
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 18
How chemotherapy treatment is administered Your course of treatment can vary in length depending on the type and / or combination of chemotherapy planned. Most courses last approximately 4 to 6 months. During this period, you will have a number of individual treatment cycles, each lasting approx 3 to 6 weeks. Treatment cycles vary according to the type or combination of chemotherapy. However, most have a rest period scheduled in before the next cycle begins to allow your healthy cells to recover. Some combinations involve having chemotherapy continuously for a few days whereas other combinations mean you take chemotherapy tablets on certain days over a period of a few weeks. There are different ways of receiving chemotherapy, depending on the specific chemotherapy treatment planned. Some chemotherapy is given by mouth (orally) and other types as an infusion into your vein (intravenous or 'IV' infusion). You can take oral chemotherapy at home, but you will need to have IV chemotherapy in hospital. You can receive some IV chemotherapy treatments via a thin plastic tube (known as a cannula) into a vein in the back of your hand or the inside of your elbow. The nurse will give your chemotherapy through this cannula, and remove the cannula after your treatment. For some chemotherapy treatments for myeloma you will need to have a central line (often a HICKMAN速 Catheter) inserted. A central line is a flexible, thin, plastic tube that goes into a central blood vessel in your chest. You receive your chemotherapy and other medications through this line, so you will not have repeated needles put into your veins. The nurses can also draw blood samples from the line. It may be particularly helpful for chemotherapy treatment that lasts for several weeks or if you have 'difficult' veins. HICKMAN速 Catheters are tunnelled under the skin of your chest, and go into a large vein in your neck, below your collar bone. The tip of the tube sits in the large vein just above your heart. Usually the doctor puts in the line under a local anaesthetic, but occasionally a general anaesthetic is used. You will initially have a stitch around the line to hold it in
18
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 19
securely. There is a small 'cuff' around the part of the line under the skin. The tissue under the skin grows around this cuff over a period of about three weeks, holding the line more securely in place. Nurses will flush the line with saline solution before you have each chemotherapy treatment to ensure that it is working normally. A diagram of a HICKMAN速 Catheter is shown in Figure 1.
Figure 1 - HICKMAN速 Catheter 1) Central line is inserted into a vein here 2) The line is tunnelled beneath the skin 3) The tube comes out here To prevent the site or the line becoming infected it is important to keep it clean at all times. Your nurse will show you how to look after your line before discharge from hospital and give you contact numbers to call if you have questions. It is important that you speak to your doctor or nurse if the area around the line becomes red, swollen or begins to ooze any pus. You should also speak to them if your temperature rises or you feel unwell generally, as these may be signs of a line infection.
Myeloma Infoline 0800 980 3332
19
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 20
You will normally keep the line in place until your course of chemotherapy is completed. A doctor or a specially trained nurse will then remove it. There are other types of line available e.g. PICC (Peripherally Inserted Central Catheter) lines. A PICC line goes into one of the large veins in your arm. The tube is then slid along the vein until it is carefully positioned with the tip sitting in one of the large veins just above the heart. Another way of receiving your chemotherapy is via a continuous infusion pump for a few days at a time. Usually a type of CADD (Continuous Ambulatory Drug Delivery) pump is used which allows you to remain mobile throughout the course of the infusion. Again, this type of infusion is normally given as an out-patient, although you will need to go to the hospital to have your chemotherapy attached to the line and set at the required rate. The pump is attached to your HICKMAN速 or PICC line by a long tube. The pump is lightweight, about the size of a small personal stereo, and is usually worn around the waist, attached to a bag or a belt.
20
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 21
Side-effects of chemotherapy treatment Although chemotherapy works well at killing myeloma cells in most cases, it also attacks normal cells and can therefore cause a number of potentially troublesome side-effects. Side-effects are most common in the parts of the body where, as with the bone marrow, there are rapidly dividing cells, i.e. the hair follicles, the skin and the lining of the mouth and digestive system. Each type of chemotherapy treatment does have its own side-effects and even the same type can produce different side-effects in different people. So it is difficult to predict precisely the side-effects any one person might have. It is important to remember that you are unlikely to get all the side-effects listed and that most are only temporary. Before you begin your treatment your nurse or doctor should explain the potential side-effects of chemotherapy and give you advice on reporting and managing symptoms.
Sickness, vomiting and appetite loss You may have sickness (nausea) or vomiting with some chemotherapy treatments. Your doctor can prescribe anti-sickness (also called anti-emetic) treatments, which you may be advised to take regularly to prevent any sickness. If you have had nausea and / or vomiting, try not to worry that this could happen again with your next cycle of chemotherapy. If you become overly anxious that this may happen with your next treatment, you may start to associate the hospital, doctors and / or nurses with feeling or being sick. Trying to take your mind off thinking about sickness often helps and, with a little bit of practice, can be a useful strategy. Fresh air may also help to calm nausea, as can relaxation, breathing exercises and lying down and resting, perhaps with some soothing background music. You may find it useful to avoid cooking smells and to ask others to prepare meals. Eating cold food and snacks, can also help until the nausea improves.
Myeloma Infoline 0800 980 3332
21
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 22
It is very important to try and keep drinking if you feel sick, to prevent dehydration. Allow your stomach to rest after vomiting, then sip cool drinks, such as still or sparkling water, or fizzy juice drinks, which will also help to freshen up your mouth. If vomiting is prolonged and you can't keep anything down, you should contact your doctor or nurse for advice. If your appetite is poor, you may find that eating small amounts regularly throughout the day helps. You may also benefit from taking nutritional supplements to ensure that you are still receiving all the essential vitamins and minerals. Ask your doctor or nurse to refer you to a dietician if you think this would help. You may also notice that you have altered sensations of taste and smells whilst on chemotherapy. Again, this should only be temporary, although you may want to eat different foods for a while.
Diarrhoea and constipation Chemotherapy treatment can have a temporary effect on your bowels, causing diarrhoea or constipation. Again it is important that you inform your doctor and / or nurse if you are concerned about any symptoms. Your doctor or nurse may be able to prescribe treatments such as anti-diarrhoea medicines or laxatives to help to relieve symptoms. Whether you have diarrhoea or constipation, the best self-care tip is to keep drinking as much fluid as possible (i.e. your normal 3 litres a day). Eating foods high in fibre can help prevent constipation, and if you have diarrhoea it is best to avoid fatty and spicy foods until the diarrhoea resolves. Diarrhoea can be more severe after having high-dose chemotherapy as part of a stem cell transplant. In this situation you may need intravenous fluids via a drip. Though diarrhoea is unpleasant and can be distressing, remember that, in most instances, it will only be temporary and you should return to your normal bowel pattern once you finish your chemotherapy treatment.
Sore mouth and throat Side-effects of chemotherapy that can commonly occur in your mouth include bleeding gums, mouth ulcers and mouth infections. Your mouth and throat may also
22
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 23
become sore (this is known as mucositis) and eating, drinking and swallowing may become difficult for a while. High-dose chemotherapy often causes mucositis, which can sometimes be quite severe. Some people find that sucking crushed ice (or an ice lolly), whilst having the chemotherapy helps to lessen this effect. If you do have mucositis then your doctor will prescribe painkillers which will help to ease any discomfort. Again, if eating and drinking are problematic, you may need IV fluids and / or nutrition until you are able to resume eating and drinking normally. Your nurse will teach you how to care for your mouth and show you how to keep it clean with mouth washes and brushes or foam sticks. It is important to recognise the signs of common infection such as oral thrush and herpes and report these to your doctor or nurse. If you have had high-dose therapy and a stem cell transplant, you will usually take medications to help prevent common fungal and viral infections in your mouth.
Hair loss Your doctor and / or nurse will explain to you, before your treatment starts if your hair is likely to be affected by chemotherapy. Not all chemotherapy causes hair loss and even when it does, it doesn't always result in complete hair loss. If you do lose your hair, this will usually start to happen within a couple of weeks of starting your chemotherapy. Most likely, you will also lose other body hair including your eyebrows and pubic hair. Hair loss is nearly always only temporary and your hair should usually start to grow back a month or so after finishing treatment. You may want to have your hair cut short before starting chemotherapy as this can help you adjust to losing your hair and make it less dramatic when it does begin to come out. If you don't lose all your hair, try to avoid hair dyes and use a very mild shampoo to avoid any scalp irritation. Most doctors and nurses fully appreciate how upsetting losing your hair can be, for men as well as women. Therefore, if you choose, you will normally have the opportunity to see a wig specialist while you still have your hair. This helps the wig specialist to advise you in choosing a wig that best matches your normal hair colour and style.
Myeloma Infoline 0800 980 3332
23
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 24
There are other options available if you decide you do not want to wear a wig. You may want to consider hats, scarves and turbans. Ask your nurse where you can buy them locally. Some people choose to wear a baseball-type cap, which can usually be bought from any department store / sports shop.
Lowered blood counts Many chemotherapy treatments suppress the activity of the bone marrow, where most of your blood cells are made. It is therefore quite common for your blood counts (red and white blood cells and platelets) to be lower than normal during your treatment. This can lead to: • Anaemia and fatigue: If your red blood count is low you are said to be anaemic and you may feel tired or fatigued, and breathless. If necessary, you may need blood transfusions or erythropoietin (EPO) injections to treat your anaemia. • Increased risk of infection: If your white blood count is low (neutropenia) you are more at risk from infection. To help reduce your risk you should try to avoid crowded places and limit your contact with young children or anyone who has a cold or the ‘flu. If you do develop signs of infection, e.g. a fever, cough or inflamed central line, you should report them to your doctor straightaway. Sometimes your doctor may prescribe antibiotics or antiviral treatment to help prevent infection occurring (prophylactic antibiotics). You may need to make some changes to your diet if your white cell count is low. Some foods carry an increased risk of infection so, in order to reduce this risk, you may need to follow a 'clean diet' until your white cell count is normal again. In general, a clean diet avoids 'high-risk' foods such as: raw or undercooked eggs; unpasteurised dairy products; live yoghurts; soft / blue cheeses; shell fish; paté; mayonnaise; meringue; takeaway foods (especially rice) or foods that have not been freshly prepared. As always, it is important to handle and store food correctly and use it by the 'best before' or 'sell by' date.
24
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 25
• Bruising and bleeding: If your platelet count is low then you may find that you bruise and bleed (e.g. nose bleeds) more easily. It is a good idea to use a soft toothbrush whilst you are having chemotherapy to avoid any damage to the gums. Again, you should let your doctor or nurse know if you have any bleeding. Your nurse will take regular blood samples whilst you are on chemotherapy to monitor changes in your blood counts. Sometimes, if your blood counts are too low, your doctor may delay the next cycle of chemotherapy until your blood counts recover. If you are neutropenic then your doctor may prescribe a short course of Growth Colony Stimulating Factor (G-CSF) injections. G-CSF is a type of protein that your body makes which can also be made synthetically. G-CSF stimulates the bone marrow to make more white blood cells and, therefore, shortens the length of time that you are neutropenic.
Effects on fertility Some, but not all, chemotherapy treatments can cause temporary or even permanent infertility. This can be quite difficult to deal with, particularly if you have been planning on having children. If this is the case, you should ask your doctor and / nurse about how your chemotherapy may affect you. For women, some chemotherapy treatments can interfere with the way the ovaries work. If you have not been through the menopause it is possible that chemotherapy may bring on an early menopause. Again, it is advisable to discuss this with your doctor and / or nurse to see if this could happen. They will be able to offer advice on how to manage the symptoms of a possible early menopause. For men, some chemotherapy treatments can affect both the number of sperm that are produced as well as their capacity to fertilise an egg. Again the type and intensity of chemotherapy will determine whether these effects will be temporary or permanent. If this is an issue for you, talk to your doctor and / or nurse before starting chemotherapy treatment.
Myeloma Infoline 0800 980 3332
25
7936 Chemo infoguide.qxp:6732 infoguide
31/3/08
06:52
Page 26
Peripheral neuropathy This term describes damage to the nerves of the peripheral nervous system. Vincristine chemotherapy can sometimes cause this. Symptoms include pain or numbness of the hands and feet, unusual sensations, or an increased sensitivity to heat or touch. It is important to let your doctor or nurse know if you get any such symptoms.
For more information please see the ‘Peripheral neuropathy’ Infosheet from Myeloma UK. To order your free copy, contact the Myeloma Infoline on 0800 980 3332
How do I know if my chemotherapy treatment is working? In order to find out how you are responding to chemotherapy you will have regular tests carried out. These tests should include blood and urine sampling and possibly a bone marrow aspirate at the end of your course of chemotherapy. In addition, you may have X-rays and / or a CT / MRI / PET scan if your doctor feels that they would be helpful. Signs that your chemotherapy treatment is working include: • A fall in the paraprotein level in your blood and / or urine • Reduced bone pain • Improvement in anaemia • A reduction in the number of plasma cells in your bone marrow One of the best indicators of response to chemotherapy is an improvement in overall general health. See Appendix 1 for details of European Group for Blood and Marrow Transplantation (EBMT) response categories and International Myeloma Working Group (IMWG) uniform response critera 2006.
26
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 27
The emotional impact of chemotherapy treatment As well as having physical side-effects, chemotherapy can have a considerable emotional impact. Being told you need chemotherapy affects everyone differently. At first you might be overwhelmed, in shock or feel numb. It is important to understand that this is a natural reaction and part of coming to terms with your situation. It may seem, at times, that your treatment takes over your life. It is likely that you will need to alter some of your daily routines in order to adapt to your treatment and any side-effects. It should help to remember that this is temporary and to plan activities that you enjoy or are important to you on your better days between treatments. Perhaps you can plan for a trip away when your chemotherapy treatment is completed. Some people find that keeping a diary or journal can help to clarify their thoughts and feelings during this time, as well as providing a practical and useful record of their treatment.
Emotional support Emotional support is important to help you cope with your chemotherapy treatment. It is very easy to feel isolated and strong emotions can often make it difficult to discuss your worries or fears. Talking to someone who understands what is happening can help to ease any feelings of isolation. Myeloma Support Groups provide an informal and comfortable atmosphere in which members can share experiences and information. Many people assume that support groups will be full of doom and gloom, but generally they are postive and full of supportive people who are facing the same issues as you. Call the Myeloma Infoline, look at our website www.myeloma.org.uk, or ask your nurse for the details of Support Groups near you. Many people find that their specialist nurse (if they have one) at the hospital or clinic is a good person to talk to. If you find your emotions difficult to cope with, you might want to ask your doctor to refer you to a counsellor or someone else who can help. You can also call one of the Myeloma Information Nurse Specialists on the Myeloma Infoline 0800 980 3332 for practical advice and emotional support.
Myeloma Infoline 0800 980 3332
27
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 28
Of course it may also be helpful not have to talk about your chemotherapy treatment. Many people find work or social situations where they can 'leave the disease behind' for a while help them cope. There is no real right or wrong way to cope emotionally. Taking your treatment one step at a time is probably the best general advice anyone can give.
Family and friends Friends and family members can offer a huge amount of emotional and practical support during your chemotherapy treatment and recovery period. They can also help take your mind off myeloma for a while. Sometimes, friends or family might find it hard to cope with the fact that you have myeloma and are on chemotherapy. They too may be scared and unable to express their concerns properly. Some may even avoid you, which can be very painful to accept. Yet it is important to realise that this may simply be because they do not know what to say. It might help to talk to them about your treatment and how you are feeling. This may help to avoid awkwardness and perhaps open up a deeper conversation.
Physical relationships It is quite common to feel a loss, or reduction, of your sex drive (libido) when you are on chemotherapy and for some months afterwards. Stress, anxiety and many of the treatments used to treat myeloma can also cause a loss of sexual desire and affect your body image. You may feel too tired or physically unable to enjoy intimacy in the same way as normal. In addition, you may feel that sex is not important when you are trying to cope with your treatment. If a physical relationship is important to you, try to talk to your partner about the way that you feel, even though you may find it difficult to start the conversation. It is easy for people to feel rejected when a physical relationship changes or ceases. Try to maintain a level of closeness, even if you do not have sex, and discuss with your partner which level of intimacy feels comfortable. In time you can gradually return to a more physical relationship.
28
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 29
For men, chemotherapy treatment can also sometimes interfere with the ability to have an erection, but this should be only a temporary side-effect. Treatments such as VIAGRA速 are not generally recommended if you have myeloma. Although chemotherapy treatments are not likely to pass into semen or vaginal fluids, most nurses recommend the use of condoms for a few days after your chemotherapy has finished. This is advised even if there is no risk of pregnancy and is intended to prevent any possible problems for your partner. Don't be too embarrassed to talk to your GP, doctor or nurse about problems with your physical relationship. They are used to this sort of discussion and may be able to provide support or prescribe a treatment that can help.
Work and financial issues It is likely that you will need to take some time off work when you are on a course of chemotherapy treatment. . Whether your break from your job is temporary or not, finding yourself no longer able to work can have an effect on your self-esteem. Whilst off work you may find it hard to relate to your colleagues. Many of your colleagues will, however, want to offer help and keep in touch. This support could be very useful if you do decide that you want to go back to work. You may find yourself facing unexpected financial worries if you are not able to work the same hours as you normally do. You might be entitled to benefits, help with travelling costs to and from the hospital and reduced prescription charges. Ask your nurse for information about this or contact the Benefit Enquiry Line on 0800 88 22 00. Depending on your age and particular cicrumstances, you may decide that early retirement is an option for you.
Myeloma Infoline 0800 980 3332
29
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 30
The future A great deal of research is taking place to find more effective and less toxic types of chemotherapy treatment and better ways of using it. It is important to understand that not everyone is suitable for every new treatment and the best and safest way to take any new chemotherapy treatment is as part of a clinical study. Clinical studies are planned investigations involving patients and are designed to test new treatments or to compare different types of current treatment. They are run according to a strict set of guidelines called a protocol and all patients involved in a clinical study are closely monitored. The results from clinical studies will help to determine which are the best treatments and so help to improve care for patients in the future. To find out more about new treatments on the horizon and about clinical studies, call Myeloma UK on 0131 557 3332.
30
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 31
Questions for your doctor / medical team Some questions that you may want to ask your doctor / medical team: • • • • • • • • • • • • • •
Why are you recommending this chemotherapy for me? What are the aims of the chemotherapy treatment? How successful has this chemotherapy been in the past? What are the alternatives to this chemotherapy? What exactly does this chemotherapy involve? How will I receive my chemotherapy? Will I need to stay in hospital? Can I keep working? How long will I be on this chemotherapy? Is this chemotherapy part of a clinical study? What about side-effects? What will they be? How long will they last? What can be done to treat side-effects? Whom do I call if I feel unwell or worried? Will this chemotherapy treatment affect my chances of having children in the future? How often will I need blood tests during my chemotherapy treatment? How will I know if the chemotherapy is working?
Tips • Write questions down and give a copy to your doctor at the beginning of your consultation • Carry a piece of paper with you to write down questions as they occur to you • Report any side-effects early to your doctor or nurse
Myeloma Infoline 0800 980 3332
31
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 32
APPENDIX 1 In general terms, disease response is measured and categorised as in the tables below. It is important to note once again that the duration of response is as important as the level of response. Table 7- European Group for Blood and Marrow Transplantation (EBMT) response categories 2001 Treatment Outcome
Definition
Complete remission / response (CR)
No detectable paraprotein in the blood and normal percentage of plasma cells in the bone marrow, or absence of myeloma cells in the bone marrow
Very good partial response (VGPR)
Greater than 90% decrease in paraprotein since start of treatment
Partial response (PR)
Greater than 50% decrease in paraprotein
Minimal response
More than 25% but less than 50% decrease in paraprotein
Stable disease (SD)
Less than 25% decrease in paraprotein but not increasing
Progressive disease
Greater than 25% increase in paraprotein or detection of new bone abnormalities
Table 8 - International Myeloma Working Group (IMWG) uniform response criteria 2006 Treatment Outcome
Definition
Stringent complete response (SCR)
CR as defined below plus normal free light chain ratio, absence of clonal cells in bone marrow
Complete response (CR)
= 5% plasma cells in bone marrow, no detectable paraprotein
Very good partial response (VGPR)
= 90% or greater reduction in blood and urine paraprotein
Partial response (PR)
= 50% reduction of paraprotein in blood and 24 hr urinary paraprotein by = 90%
Stable disease (SD)
Not meeting criteria for CR, VGPR, PR or progressive disease
Progressive disease
Greater than 25% increase in paraprotein or detection of new bone abnormalities
32
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 33
Medical terms explained Alkylating agents: A chemotherapy treatment such as melphalan or cyclophosphamide. Alkylating refers to the way the treatment affects the DNA of myeloma cells and blocks cell division. Anaemia: A below normal number of red blood cells in the blood. This reduces the ability of the blood to supply oxygen to the body, causing fatigue and weakness. Cancer: A malignant disease that is caused by abnormal and uncontrolled cell division and multiplication. Cannula: A thin hollow tube that is inserted into a vein in order to administer intravenous drugs and fluids. Cell: The individual unit from which all the organs and tissues of the body are formed. All living organisms are composed of one or more cells. Cell division: Process by which a cell produces two cells, called daughter cells, making possible cell multiplication. Clinical Study: A research study of a new treatment that involves patients. Each study is designed to find better ways to prevent, detect, diagnose, or treat disease and to answer scientific questions. Cytotoxic: A treatment that is toxic to cells, cell-killing. Cytotoxic antibiotics: Cytotoxic antibiotics, e.g. doxorubicin, adhere to the cell’s DNA, disrupt its function and therefore prevent the cell from dividing. DNA: Or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Erythropoietin (EPO): A hormone produced by the kidneys. Myeloma patients with damaged kidneys don’t produce enough erythropoietin and can become anaemic. Injections with synthetic erythropoietin can be helpful. Synthetic erythropoietin can be used prophylactically before chemotherapy and as a supportive therapy after chemotherapy to avoid anaemia. Myeloma Infoline 0800 980 3332
33
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 34
Fatigue: Fatigue means feeling exceptionally tired, lethargic or exhausted - all, or most, of the time. Unlike normal tiredness, fatigue is not relieved by sleep or rest. Immunoglobulins: Also known as antibodies, immunoglobulins are proteins found in the blood which are produced by cells of the immune systems, called plasma cells. Their function is to bind to foreign antigens found on the surface of bacteria and viruses. Immunomodulatory treatments: This is a type of treatment (e.g. thalidomide) that acts on the cells involved in the body’s immune system. Immunomodulatory treatment affect the levels of substances produced by the body as part of the immune response to disease. Intravenous: Fluids or treatments that are administered intravenously are given through a vein. Neutropenia: A low number of neutrophils in the blood. Neutrophils are white blood cells that fight infection. Palliative care: Sometimes referred to as symptom control, palliative care is the name given to the range of treatments that are given to relieve the symptoms caused by myeloma. Palliative care does not alter the course of myeloma but can improve quality of life. The term is used especially when active treatment is no longer appropriate, e.g. pain control. Paraprotein: An antibody-like protein produced by the abnormal plasma cells in myeloma. It is found in the blood and sometimes also in the urine. It is also called monoclonal protein, myeloma protein, M-spike, M-protein or M-band. Plant alkaloids: Plant alkaloids, e.g. vincristine, are a type of chemotherapy treatments that work by disrupting the process of cell division. Plasma cells: Special white blood cells that produce antibodies. These are the malignant cells in myeloma. Normal plasma cells produce antibodies to fight infection. In myeloma, malignant plasma cells produce large numbers of abnormal antibodies that lack the capability to fight infection. The abnormal antibodies are the paraprotein, or M-protein. Plasma cells also produce other chemicals that can cause organ and tissue damage (e.g. anaemia, kidney damage and nerve damage).
34
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 35
Platelets: Platelets are a type of blood cell that is integral to the normal clotting mechanism of blood. Proteasome Inhibitors: The proteasome is a large structure inside all cells that controls cell growth and function. It works by breaking down the many different proteins that control the cell’s lifecycle. Proteasome inhibitors (e.g.Velcade) work by blocking the proteasome, which can lead to slowed cell growth or cell death. Red blood cells: Red blood cells carry oxygen in the form of haemoglobin to body cells, and carbon dioxide away from body cells. Relapse: Relapsing disease is disease that has responded to prior treatment but is showing signs of returning. Refractory: Refractory myeloma is disease that has failed to respond to treatment. Side-effects: Problems that occur when treatment affects healthy cells. Common side-effects of standard cancer treatments are fatigue, nausea, vomiting, decreased blood cell counts, hair loss and mouth sores. New treatments being tested may have these or other unknown side-effects. Stem cell transplant: In myeloma, stem cell transplants are performed in order to allow the bone marrow to recover after high-dose chemotherapy treatment is given. Stem cells are taken from blood or bone marrow, and, following high-dose chemotherapy treatment, these stem cells are given back to renew the patient’s blood forming cells. In myeloma the most commonly used types of transplant are: • Autologous: The patient’s own stem cells are used for re-infusion after treatment. This is the most common form of transplant used in myeloma • Allogeneic: The person donating the stem cells is a different person, usually a family member, with a compatible tissue type • Mini-transplant: This is a type of allogeneic transplant in which lower doses of chemotherapy are used than in standard allogeneic transplants. This is to try to avoid some of the side-effects associated with the higher dose treatment
Myeloma Infoline 0800 980 3332
35
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 36
Steroids: Steroids are hormonal substances naturally produced in the body but can also be synthetically manufactured. There are many different types of steroids, those used in the treatment of myeloma are known as glucocorticoids, e.g. dexamethasone, prednisolone. These steroids can suppress inflammation and the immune response. Supportive care: Supportive care refers to the range of treatments given to prevent and control the complications and side-effects of myeloma and its treatment, e.g. bisphosphonates and blood transfusions. White blood cells: White blood cells are responsible for protecting the body from invasion by foreign substances such as bacteria and viruses.
36
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 37
Further information and useful organisations British Association for Counselling and Psychotherapy (BACP) www.bacp.co.uk 0870 443 5252 (Monday-Friday, 8.45am-5pm) BACP provides information about counselling and gives a list of local registered counsellors. British Committee for Standards in Haematology (BCSH) www.bcshguidelines.com The BCSH provides haematologists with up-to-date information on the diagnosis and treatment of myeloma. Its website contains a range of position papers and guidelines, including the Guidelines on the Diagnosis and Management of Multiple Myeloma. Cancerbackup www.cancerbackup.org.uk 0808 800 1234 (Monday-Friday, 9am-8pm) Cancerbackup is Europe’s leading cancer information charity. It publishes a wide range of patient information. Its website contains over 4,500 pages of up-to-date cancer information. Its helpline is staffed by trained oncology nurses who provide information and support to people affected by cancer. Cancer Black Care www.cancerblackcare.org 020 8961 4151 (Monday-Friday, 9am-5pm) Provides information, advice and support services for members of the black and minority ethnic communities. Cancer Research UK www.cancerhelp.org.uk 0800 226 237 (Monday-Friday, 9am-5pm) Its website contains patient information about all types of cancer and gives details of current research and clinical studies. Its helpline is staffed by specialist cancer nurses who provide information to people affected by cancer.
Myeloma Infoline 0800 980 3332
37
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 38
Carers UK www.carersuk.org 0808 808 7777 (Wednesday and Thursday, 10am-12pm and 2pm-4pm) Carers UK provides advice, information and support for carers. It produces a directory of national and local carer organisations and can show you where to get help in your area. Depression Alliance www.depressionalliance.org 0845 123 2320 (Information pack request line) Provides information, support and understanding to those affected by depression and coordinates a network of self-help groups throughout the UK. Depression Alliance also produces a wide range of publications covering various aspects of depression. International Myeloma Foundation (IMF) www.myeloma.org 00 1 818 487 7455 Provides information about all aspects of myeloma and its treatment, including clinical studies being conducted in the US and around the world. Irish Cancer Society (Republic of Ireland) www.cancer.ie 1 800 200 700 (Monday to Friday, 10am–5.30pm; from UK dial 00 3531 2310 500) Its helpline provides advice, support and information to people in the Republic of Ireland affected by cancer. Publishes a range of patient information, including a booklet on myeloma. Macmillan Cancer Support www.macmillan.org.uk 0808 808 2020 (Monday-Friday, 9am-10pm) Its helpline is staffed by specialist advisors who provide information, practical and emotional support to those affected by cancer. Macmillan's other services include Macmillan nurses and patient grants, as well as information about over 750 cancer self-help groups across the UK. Medic Alert www.medicalert.org.uk 0800 581 420 (Monday-Friday, 9am-5pm) Medic Alert provides a life-saving identification system for individuals with hidden medical conditions. 38
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 39
Multiple Myeloma Research Foundation (MMRF) www.multiplemyeloma.org 00 1 203 972 1250 The MMRF is a US-based private funder of worldwide myeloma-specific research. Its website provides information about myeloma treatments and international clinical studies. National Institute for Health and Clinical Excellence (NICE) www.nice.org.uk NICE produces guidelines on NHS treatment and improving outcomes in haematological cancers and guidance for the public on haematological cancer services. NHS Direct / NHS24 www.nhsdirect.nhs.uk In England, Northern Ireland and Wales call NHS Direct on 0845 46 47 In Scotland call NHS24 on 08454 24 24 24. Staffed by trained medical professionals, it provides 24-hour access to information about all aspects of health and healthcare. Penny Brohn Cancer Care (formerly Bristol Cancer Help Centre) www.pennybrohncancercare.org 0845 123 2310 (Monday–Friday, 9.30am-5pm) The Bristol centre offers complementary cancer care to work alongside medical treatment. Its helpline provides emotional support and information about complementary therapists and services in your area. Relate www.relate.org.uk 0845 130 4016 (Monday- Friday, 9am-5pm) Relate offers a confidential counselling service to couples or individuals experiencing difficulties in their relationship. Relate provides support face-to-face, by phone and through its website. Ulster Cancer Foundation (Northern Ireland) www.ulstercancer.org 0800 783 3339 (Monday-Friday, 9am-5pm) Offers information, support and counselling to people affected by cancer in Northern Ireland. Its helpline is staffed by specially trained nurses with experience in cancer care.
Myeloma Infoline 0800 980 3332
39
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 40
With Myeloma UK you can... Call our Myeloma Infoline on 0800 980 3332 You will immediately access information and support relating to all aspects of myeloma. Your call will be answered in confidence by Myeloma Information Nurse Specialists who are supported by medical and scientific advisors. Lines are open Monday to Friday, 9am to 5pm, and are free to phone from anywhere in the UK. From outside the UK call +44 131 557 3332 (charged at normal rate).
Myeloma Infopack The Myeloma Infopack contains general information about myeloma. treatment options and disease management. It also has information about Myeloma UK and the range of service available to those affected by myeloma.
Contact us by email If you have a specific question about any aspect of myeloma, treatment or living with myeloma, you can also contact our Myeloma Information Nurse Specialists by email at askthenurse@myeloma.org.uk
Order our free patient information Myeloma UK has a range of Essential Guides, Infoguides and Infosheets which give information on myeloma and related disorders, providing details of treatment options, disease management and practical support.
Attend our Patient and Family Myeloma Infodays These are full-day meetings, where you can learn about the latest in the treatment and management of myeloma from a panel of experts. They provide a valuable opportunity to meet others affected by myeloma.
Subscribe to Myeloma Matters The only myeloma-specific newsletter available in the UK, ‘Myeloma Matters’ offers a comprehensive range of features, articles and stories to help you keep abreast of the latest developments in treatment and research.
Visit our website - www.myeloma.org.uk Developed to provide immediate, 24-hour access to information about myeloma for patients, families, carers and healthcare professionals. 40
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 41
Other information available from Myeloma UK Booklets Myeloma – Your Essential Guide Living with Myeloma - Your Essential Guide Infoguides Balloon Kyphoplasty Bone Disease and Bisphosphonates Clinical Studies High-Dose Therapy and Stem Cell Transplantation Revlimid Serum Free Light Chain Assay Thalidomide Velcade Infosheets Infosheet topics include: Constipation; Erythopoietin; Fatigue; Growth Factors; Managing Your Finances, (including Benefits); Mouthcare; Nutrition / Diet; Osteonecrosis of the Jaw; Pain; Peripheral Neuropathy; Plasmapheresis; Radiotherapy; Steroids; Support Groups; The Kidney; Travel Insurance; Travelling with Myeloma Leaflets Myeloma – An Introduction To order these free publications please contact Myeloma UK. Myeloma Infoline: 0800 980 3332 (freephone number) or 0131 557 3332 www.myeloma.org.uk email: myelomauk@myeloma.org.uk
Myeloma Infoline 0800 980 3332
41
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 42
We need your help Each year, Myeloma UK sends Infoguides and Infosheets to nearly 10,000 patients and their families, and helps thousands more through providing services such as the Myeloma Infoline and Patient and Family Myeloma Infodays.
That is why we need your help We depend on the support and generous donations from people like you to provide these important services which are available free to myeloma patients, their families and carers.
Will you help us to help others? • £5 will pay for an Infopack to be sent to help one more patient • £20 will allow one of our highly trained Myeloma Information Nurse Specialists to help two callers on our Myeloma Infoline • £50 will pay for a family of three to attend a Myeloma Infoday • £250 will pay for 2,000 patient information Infosheets Simply choose the amount that is right for you, or, if you prefer, choose an amount of your own. To donate you can either post your donation (by cheque or CAF), use your credit card to donate by telephone or use the Myeloma UK website www.myeloma.org.uk We can make your money go further if you are a UK taxpayer. If you pay tax at the basic rate we can claim 24p* on every pound you donate. For example, if you donate £10 then we are able to claim back £2.40 , so your donation becomes £12.40. This extra comes from the taxman and doesn’t cost you anything. This process is called Gift Aid. (*April 2008)
42
www.myeloma.org.uk
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 43
Published by Myeloma UK Publication date: March 2008 Review date: March 2009 Author: Mandy Calder RGN and Monica Morris, RGN Myeloma UK HICKMAN速 Catheter is a registered trade mark of C.R.Bard, Inc Myeloma UK would like to thank Kate Bebb, lay reviewer; Rodney Benjamin, patient; Ailsa Hayes, Myeloma CNS; Dr Alastair Smith, Consultant Haematologist; Lisa Wilks, Chemotherapy Nurse Specialist Trainer, for their help and advice in the compilation of this Infoguide. All Myeloma UK publications are reviewed by patients and healthcare professionals before publication.
7936 Chemo infoguide.qxp:6732 infoguide
17/3/08
12:54
Page 44
Myeloma Infoline 0800 980 3332 www.myeloma.org.uk
For more information or to access any of the information and support services listed, contact Myeloma UK Myeloma UK Broughton House 31 Dunedin Street Edinburgh EH7 4JG Tel: 0131 557 3332 Fax: 0131 556 9720 email: myelomauk@myeloma.org.uk Myeloma Infoline: 0800 980 3332 www.myeloma.org.uk
Charity No. SC 026116
Annual Myeloma Awareness Week 21 - 28 June